There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. After-hours trades for Collegium Pharmaceutical Inc (COLL) shows that investor sentiment remained same, with the stock’s consolidated last price to $25.19. The Collegium Pharmaceutical Inc has recorded 130,338 volume in the after hours trading session. Yahoo Finance discussed the stock recently as it posted Collegium Announces $25 Million Accelerated Share Repurchase Program.
This NASDAQ-listed company operates within the Drug Manufacturers – Specialty & Generic industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $25.19 and fluctuated between $25.41 as its day high and $24.48 as its day low. The current market capitalization of Collegium Pharmaceutical Inc is $821.45M. A total of 0.61 million shares were traded on the day, compared to an average of 276.21K shares.
Insider trades can also provide insight into a stock’s future direction. During the recent three months, COLL has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 35 BUYs and 43 SELLs from insiders. Insiders purchased 951,535 shares during that period but sold 851,078.
In the most recent transaction, Kuhlmann Shirley R. sold 17,984 shares of COLL for 21.72 per share on Jun 26. After the transaction, the EVP and General Counsel now owns 119,518 company shares. In a previous transaction on Jun 02, Ciaffoni Joseph sold 31,272 shares at 21.60 per share. COLL shares that President and CEO owns now total 275,000.
Among the insiders who sold shares, Ciaffoni Joseph disposed of 31,272 shares on Jun 01 at a per-share price of $22.09. This resulted in the President and CEO holding 306,272 shares of COLL after the transaction. In another insider transaction, Ciaffoni Joseph sold 31,272 shares at $21.87 per share on May 31. Company shares held by the President and CEO now total 337,544.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for COLL in the last 3 months, the mean price target is $33.50 with high estimates of $37.00 and low estimates of $30.00. In terms of 52-week highs and lows, COLL has a high of $30.22 and a low of $18.95.
As of this writing, COLL has an earnings estimate of $0.74 per share for the current quarter. EPS was calculated based on a consensus of 3 estimates, with a high estimate of $0.83 per share and a lower estimate of $0.67. The company reported an EPS of $0.34 in the last quarter, which was 17.20% higher than expectations of $0.29.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. COLL’s latest balance sheet shows that the firm has $186.43M in Cash & Short Term Investments as of fiscal 2021. There were $258.75M in debt and $230.40M in liabilities at the time. Its Book Value Per Share was $5.41, while its Total Shareholder’s Equity was $202.93M.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for COLL is Buy with a score of 4.50.